| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 31-Dec-06 | | Total Revenue | 247,430 | 353,155 | 360,376 | | Cost of Revenue | 217,992 | 304,183 | 283,400 | | | Gross Profit | 29,438 | 48,972 | 76,976 | | | Operating Expenses | | Research Development | 14,864 | 26,281 | 13,645 | | Selling General and Administrative | 47,938 | 70,397 | 48,944 | | Non Recurring | 685 | 23,872 | 2,840 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (34,049) | (71,578) | 11,547 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,138 | 8,596 | 8,310 | | Earnings Before Interest And Taxes | (30,911) | (62,982) | 19,857 | | Interest Expense |
-
| 8 | 13 | | Income Before Tax | (30,911) | (62,990) | 19,844 | | Income Tax Expense | 376 | 6,567 | 8,372 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31,287) | (69,557) | 11,472 | | | Non-recurring Events | | Discontinued Operations | (22,941) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (54,228) | (69,557) | 11,472 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($54,228) | ($69,557) | $11,472 |
|
0.52% Nasdaq 
Income Statement
